Carmell Co. (NASDAQ:CTCX) Sees Significant Growth in Short Interest

Carmell Co. (NASDAQ:CTCX) saw a significant growth in short interest in May. As of May 31st, there was short interest totalling 35,500 shares, a growth of 18.3% from the May 15th total of 30,000 shares. Currently, 0.3% of the shares of the stock are short sold. Based on an average trading volume of 10,700 shares, the short-interest ratio is currently 3.3 days.

Carmell Stock Performance

Carmell stock opened at $1.83 on Tuesday. Carmell has a 12-month low of $1.70 and a 12-month high of $13.31. The firm has a 50-day moving average price of $2.29 and a 200-day moving average price of $2.91.

Carmell (NASDAQ:CTCX) last released its quarterly earnings results on Wednesday, May 15th. The company reported ($0.16) EPS for the quarter.

Institutional Investors Weigh In On Carmell

Several large investors have recently modified their holdings of the business. Meteora Capital LLC bought a new position in shares of Carmell during the 3rd quarter worth approximately $6,416,000. Linden Advisors LP bought a new position in shares of Carmell during the 3rd quarter worth approximately $270,000. Finally, Hubbell Strickland Wealth Management LLC acquired a new position in Carmell during the 1st quarter valued at approximately $32,000. Institutional investors own 24.22% of the company’s stock.

About Carmell

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.